user

INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: UPDATES FROM A PHASE 2 TRIAL

被引：0
|
作者：
Patel, Sunil
Collins, Connie
Singla, Nirmish
Gabrielson, Andrew
Bivalacqua, Trinity J.
Hahn, Noah
Kates, Max
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP59-15
引用
收藏
页码：E1008 / E1008
页数：1
相关论文
共 50 条
  • [1] A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Patel, Sunil H.
    Gabrielson, Andrew T.
    Chan, Sin
    Schwartz, Deborah
    Collins, Connie
    Singla, Nirmish
    Trock, Bruce
    Bivalacqua, Trinity J.
    Hahn, Noah
    Kates, Max R.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E245 - E246
  • [2] Intravesical gemcitabine and docetaxel in the treatment of BCG-naive non-muscle invasive urothelial carcinoma of the bladder: Updates from a phase 2 trial.
    Patel, Sunil H.
    Gabrielson, Andrew
    Collins, Connie
    Singla, Nirmish
    Bivalacqua, Trinity
    Hahn, Noah M.
    Kates, Max R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Phase 2 trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    Gray, Jillian
    Ingram, Justin
    Stein, Mark N.
    McKiernan, James M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, G. Joel
    Anderson, Christopher
    Kates, Max
    Buckley-Matura, Bridget
    Sui, Wilson
    Lee, Shing M.
    Holder, Dara
    Virk, Renu
    Drake, Charles
    Abate-Shen, Cory
    McKiernan, James
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E623 - E623
  • [5] COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Joffe, Benjamin I.
    Christin, John R.
    Le Coz, Clementine
    Pak, Jamie S.
    Laplaca, Caroline
    Reyes, Helena Vila
    DeCastro, G. Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    McKiernan, James M.
    Lenis, Andrew T.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E247 - E248
  • [6] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, Guarionex
    Sui, Wilson
    Pak, Jamie
    Abate-Shen, Cory
    Lee, Shing
    Anderson, Christopher
    Holder, Dara
    McKiernan, James
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
  • [7] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Steinberg, Ryan
    Thomas, Lewis
    O'Donnell, Michael
    Nepple, Kenneth
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E301 - E301
  • [8] Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    [J]. BLADDER CANCER, 2015, 1 (01) : 65 - 72
  • [9] Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer
    Bakula, Mirko
    Hudolin, Tvrtko
    Knezevic, Nikola
    Zimak, Zoran
    Andelic, Jerko
    Juric, Ilija
    Gamulin, Marija
    Gnjidic, Milena
    Kastelan, Zeljko
    [J]. LIFE-BASEL, 2024, 14 (07):
  • [10] Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naive patients with non-muscle invasive bladder cancer.
    Thomas, Lewis
    Steinberg, Ryan
    Nepple, Kenneth Gerard
    O'Donnell, Michael A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345